Work with LifeSpan to design a custom immunohistochemistry to address your specific biological question. Outsource the entire localization process without having to
worry about finding and characterizing target specific antibodies, sourcing and validating difficult-to-find tissues, and having the ability to interpret the resulting
immunostaining in relation to complex human pathologies.
TCR Screening Services
Test your therapeutic antibodies in immunohistochemistry against a broad panel of normal frozen human tissue types in order to determine potential unintended binding.
Our non-GLP TCR services are designed on the FDA recommendation outlined in their "Points to Consider in the Manufacture and Testing of Monoclonal Antibody Products for Human Use".
CSNK2A1 Antibody, Casein kinase II alpha Antibody, Casein kinase II subunit alpha Antibody, Ck2 alpha Antibody, CK2 catalytic subunit alpha Antibody, CKII Antibody, CKIIalpha Antibody, CK2A1 Antibody, CKII alpha Antibody, Protein kinase CK2 Antibody, Casein kinase 2 alpha Antibody, CK II alpha Antibody
Catalytic subunit of a constitutively active serine/threonine-protein kinase complex that phosphorylates a large number of substrates containing acidic residues C-terminal to the phosphorylated serine or threonine. Regulates numerous cellular processes, such as cell cycle progression, apoptosis and transcription, as well as viral infection. May act as a regulatory node which integrates and coordinates numerous signals leading to an appropriate cellular response.
Western blot of CK2a (Phospho- Thr360/Ser362) antibody (#11572) and CK2a antibody (#21572) in vitro kinase assay. Both purified ERK2 and CK2 were used. CK2a (Phospho-Thr360/Ser362) antibody could recognize ERK2 phosphorylated wild type CK2a and CK2a when Ser362 was mutated to alanine .